Morning Read: A Pfizer-Allergan acquisition is in the works, Allergan’s Warner Chilcott coughs up $125M to settle kickback charges
Pfizer and Allergan are in acquisition talks.
What does Warner Chilcott have to offer a potential buyer?
As Warner Chilcott (NASDAQ: WCRX) acknowledged in an announcement Monday that it is considering strategic options, it’s good time to look at what the company has to offer a prospective buyer in what has become a busy M&A landscape. The Irish company’s products were mostly acquired from Bristol-Myers Squibb, Lilly, Pfizer and Procter & Gamble. […]
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.